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Abstract
Background Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, 
is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.
Methods Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 
1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating 
scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to 
either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters 
to these diagnoses.
Results A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including 
demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision 
rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative 
predictive value of approximately 95%.
Conclusions The present machine-learned analysis showed that, even with a large set of parameters acquired from a large 
cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for 
accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, 
to exclude the possibility of persistent pain developing in a woman being treated for breast cancer.
Keywords Pain · Bioinformatics · Data science · Chronification
Introduction
Breast cancer is the most common cancer in women in the 
developed countries and its prevalence is steadily increas-
ing [3, 15, 17]. Improved management of breast cancer has 
made survivorship issues important [41], including moder-
ate to severe pain reported with a prevalence of about 15% 
at 1 year from surgery [37]. About 34% of these patients 
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have signs of neuropathic pain [48] and the pain can last for 
several years [36], significantly impairing their quality of 
life [52]. Prevention of persistent post-surgical pain requires 
early identification of patients at the highest risk to initiate 
appropriate medical and psychosocial interventions [10, 43]. 
On the other hand, identifying patients in whom the possibil-
ity of persistent pain can be dismissed with high confidence 
may be similarly desirable as this could prevent unnecessary 
therapeutic interventions.
The prediction of persistent pain after a surgical interven-
tion is therefore an active research topic that has already led 
to several proposed solutions, as indicated by 160 hits in 
a PubMed search at https ://www.ncbi.nlm.nih.gov/pubme 
d for “(chronic or persistent) and pain and prediction and 
*surgery” on December 6, 2017. However, diagnostic tools 
providing such a prediction have remained an unmet clinical 
need. Considering that pain has a highly complex patho-
physiology [22, 47] and is triggered by several different 
causes including cancer [44] and surgery [25], such tools 
may require a combination of different parameters. However, 
in addition to proposals of biochemical or genetic markers, 
clinical and psychological parameters have remained a basis 
of predictive assessments of the development of pain after 
surgery [4, 11, 30, 37].
In the present analysis, more than 500 parameters were 
available from a 3-year follow-up of 1,000 women operated 
on for breast cancer [49]. This provided a robust basis for 
clinical judgment of pain persistence and, using parameters 
acquired during the perioperative period, allowed the pre-
diction of either persistent pain at later stages or its unlike-
liness. Previous analyses indicated the suitability of these 
parameters for the prediction of persistent pain [32, 49]; 
however, the present analysis used a data-driven approach, 
without prior hypotheses on the most important parameters, 
to create a predictive diagnostic tool for persistent pain, or 




The study followed the Declaration of Helsinki, and both 
the Coordinating Ethics Committee (journal number 136/
E6/2006) and the Ethics Committee of the Department of 
Surgery (148/E6/05) of the Hospital District of Helsinki and 
Uusimaa approved the study protocol. Written informed con-
sent for data acquisition and publication in an anonymized 
manner was obtained from each participating patient. One 
thousand women with unilateral non-metastasized breast 
cancer, aged 28–75 years (Fig. 1) were enrolled during the 
preoperative visit before breast cancer surgery. They were 
treated at the Helsinki University Hospital between 2006 
and 2010 with breast-conserving surgery or mastectomy, 
and sentinel node biopsy and/or axillary clearance. Exclu-
sion criteria were neoadjuvant therapy, i.e., administration of 
chemotherapy to shrink the tumor before the main surgical 
treatment [54], and immediate breast reconstruction surgery. 
Of the 1,536 consecutive eligible patients, 1,149 patients 
were invited to participate, of whom 126 patients declined 
and 23 were withdrawn.
The cohort has previously been described in detail [24, 
37]. Briefly, perioperative analgesia was standardized, con-
sisting of oral acetaminophen and intravenous oxycodone, 
titrated first by a research nurse in the post-anesthesia care 
unit followed by patient-controlled analgesia on the ward. 
No regional anesthesia was used. Analgesia at home during 
the first postoperative week consisted of ibuprofen, aceta-
minophen or a combination of acetaminophen and codeine. 
Adjuvant treatments were given according to international 
guidelines [37].
Data acquisition
Acquisition of data on pain during the follow-up
A full listing of the acquired data is provided in Supplemen-
tary Table 1. Pain was assessed using a standard 11-point 
Numerical Rating Scale (NRS) ranging from 0 to 10, 0 indi-
cating “no pain” and 10 the “worst imaginable pain” [12]. 
The mean daily post-surgical pain intensity was recorded 
during the first postoperative week with patient-rated paper 
diaries. At 1, 6, 12, 24, and 36 months after surgery, ques-
tionnaires were posted to all patients asking about the pres-
ence, location, and intensity of pain, pain interference, and 
mood. The patients reported, as a single rating, the worst 
pain, either at rest or during movement, in any of the sur-
gery-related locations (breast, axilla, upper arm) during the 
previous week. The questionnaires about pain interference 
with daily life and sleep were developed for this study. The 
presence or absence of persistent pain was established from 
these questions at 12–36 months.
Acquisition of candidate parameters for prediction of pain 
persistence
To predict the development or absence of persistent pain 
after breast cancer surgery, the so-called “input space” of 
542 different variables was acquired from the data collected 
before surgery, during the perioperative phase, and at follow-
up until 6 months after surgery. The acquired variables, in 
the present context of machine-learning [39] called param-
eters or “features,” included the patients’ medical history 
(diseases, medications, number of previous surgeries), and 
demographic data. In addition, pain-related data included 
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the presence of persistent pain of any kind, preoperative pain 
in the operated area (breast, axilla, arm), opioid (remifen-
tanil) consumption during surgery, immediate postopera-
tive pain intensity ratings (at rest and during movement), 
amount of oxycodone needed for satisfactory pain relief for 
the first time after surgery, oxycodone consumption during 
20 h after surgery, pain intensity, and analgesic consump-
tion during the first postoperative week. The parameters also 
included surgical data such as type of surgery (mastectomy 
or breast-conserving surgery, axillary clearance, sentinel 
node biopsy), complications of surgery and re-operations, 
pathology data such as tumor and lymph node character-
istics. Finally, data on adjuvant therapies (chemotherapy, 
radiation therapy, endocrine therapy) were acquired.
In the follow-up questionnaires, detailed pain-related 
parameters about specific pain locations were sought and 
the patients were asked whether the pain had disturbed 
their sleep or otherwise affected their life (11-points NRS 
ranging from 0 to 10, 0 indicating “not at all” and 10 “very 
much”), and what analgesics they used, if any. Psychologi-
cal data were acquired with questionnaires including Beck’s 
Depression Inventory (BDI) [2] and Spielberger’s State-Trait 
Anxiety Inventory (STAI) [51] before surgery and at the 
follow-up times. The State-Trait Anger Expression Inventory 
(STAXI2) [50] was used preoperatively and at 6 months. 
All data were entered manually into Excel files and double-
checked by two investigators.
Data analysis
Data analysis was performed using the MATLAB numeri-
cal computing environment (version 8.3.0.532, MathWorks, 
Natick, MS, USA) and R software package (version 3.2.3 for 
Linux; http://CRAN.R-proje ct.org/ [45]).
Application of the previously proposed six-factor risk 
index for persisting pain was performed according to the 
instructions in Table A1 in the appendix of [49]. In brief, 
the six items “age,” “chronic pain of any kind,” “number of 
previous operations,” “body mass index,” “preoperative pain 
in the area to be operated on,” and “smoking” were weighted 
according to these instructions. For example, age ≤ 39 years 
was given a weight of 0, age 40–69 years a weight of 8, and 
age ≥ 70 years a weight of 16. The respective weights for 
the six parameters were added from an index of 20, patients 
were predicted as potentially developing persisting pain.
Given the broader data basis available in the present 
analysis, a novel and independently designed analysis was 
performed to assess whether the classification performance 
could be improved. This was approached using supervised 
machine-learning [39] and feature-selection techniques 
Fig. 1  Flow chart showing the 
classification of the patients 
on the basis of the 3-year 
development of pain following 
breast cancer surgery. A total 
of 853 women fell into the two 
main groups of persisting or 
non-persisting pain, accord-
ing to the criteria displayed in 
the gray-shaded frames. This 
was the main cohort that was 
analyzed. The remaining 143 
women in whom the criteria for 
class assignment applied only 
partly were therefore excluded 
from machine-learned classifier 
establishment but they were 
used as an exploratory short-
ened “test” data set. Incomplete 
returns of pain questionnaires 
were dealt with by imputa-
tion as detailed in the methods 
section
1,000 paents
NRSmonth36 ≥ 4 and
NRSmonth12..month36 > 0 and
(NRSmonth36 − NRSmonth24) > 0
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[19], aimed at identifying parameters from the data acquired 
before surgery and up to the sixth month after surgery, which 
could predict the presence or absence of persisting pain in 
the area operated on during the 3-year follow-up available 
for the present analysis. However, as before [49] an interpret-
able and clinically immediately applicable diagnostic tool 
was desired and therefore, a rule-based classifier [59] was 
again chosen forming a questionnaire with “yes/no” items 
(decision rules). The analysis was performed in four main 
steps as shown in Fig. 2 and comprising (i) establishment 
of the so-called output space, (i) feature pre-selection, (iii) 
feature selection, and (iv) classifier building, which are 
described briefly in the following; more detailed descrip-
tions are provided in the Supplementary materials.
First, the so-called “output space” was established (Fig. 2 
left part) by identifying the groups or “classes” of patients 
with respect to persistent pain. In the following, the term 
“persisting pain group” and “non-persisting pain group” 
or “classes” will be used when referring to these groups. 
Subsequently, the input or feature space was analyzed to 
3 NRS queries
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Fig. 2  Flow chart of the data analysis. The figure provides an over-
view on the applied machine-learning approach in four steps (indi-
cated in blue: output space preparation, input space feature pre-selec-
tion, feature selection and classifier building, including validation). 
The white frames show the variable flow; the gray frames depict the 
bioinformatics operation applied on the variables. During feature pre-
selection and feature selection, the number of candidate variables 
qualifying as component s of a diagnostic tool respectively classi-
fier was stepwise reduced (initially 542, finally 21), forwarding to the 
next analytical step only those features that had passed the criteria of 
the actual selection procedure. The Bayesian decision limit and Kull-
back–Leibler divergence refer to the respective standard procedure 
presented elsewhere [28, 35]
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identify those parameters that provided a valid assignment 
of a patient to the classes of persisting or non-persisting 
pain. This included the second analytical (Fig. 2 right part) 
step comprising a “feature” pre-selection, during which 
all parameters were analyzed with respect to differences 
between the “persisting pain” and “non-persisting pain” 
groups, established in the output space. This was based on 
the assessment of effect sizes between the two patient groups 
depending on the numerical scaling of the parameters as 
continuous (interval-scaled), discrete or binary (“yes”/”no”).
Those parameters that had passed that step were taken 
into the third analytical step of feature selection (Fig. 2 
right part), which eliminated all parameters distinguishing 
between the persisting pain and non-persisting pain groups 
but not providing additional relevant information justifying 
their inclusion in a tool (“classifier”) predictive of persist-
ing pain. This applied a so-called calculated ABC analysis 
[56]. This is an inventory categorization technique originally 
developed for problems in economics to search for a subset 
with the minimum possible effort that gives the maximum 
yield [23, 42]. The remaining parameters, in the following 
called “features,” were taken into the fourth step of the data 
analysis (Fig. 2 bottom right) in which the predictive tool 
or “classifier” was constructed and assessed with respect 
to standard test performance measures. To obtain a robust 
selection of parameters (features), Monte-Carlo resampling 
was used repeatedly.
Results
Persisting versus non‑persisting pain groups
The recovery rate of the pain questionnaires was high with 
95.3, 91.3, 90.2, 90.2, and 87.4% returned in months 1, 6, 
12, 24, and 36, respectively. This sufficed for a valid classi-
fication of the subjects into two main diagnostic groups that 
displayed temporal courses of pain for 3 years after breast 
cancer surgery obtained in the first analytical step aimed at 
establishing the so-called output step (Fig. 2 left). Of the 
1000 analyzed women (Fig. 1), 779 had a favorable time 
course of postoperative pain and belonged to the “non-per-
sisting pain” group characterized by  NRSmonth12...month36 ≤ 3 
(Fig. 1 left). By contrast, in 74 women, the pain followed 
the opposite path typical for the “persisting pain” group 
characterized by  NRSmonth36 ≥ 4 and  NRSmonth12...month36 > 0 
and  (NRSmonth36 − NRSmonth24) ≥ 0 (Fig. 1 middle). Four of 
these women were excluded from the analysis due to breast 
reconstruction surgery within the previous month, which 
hampered the clear association of pain at month 36 to the 
original surgery. Finally, the criteria for class assignment 
were not completely met in the remaining 143 women who 
were therefore excluded from machine-learned classifier 
establishment (Fig. 1 right) but were used as an exploratory 
“test” data set.
Classifier establishment
Supervised machine-learning was applied to map 
the “input space,” i.e., the acquired “features” (the 
542 parameters), x, to the “classes,” i.e., the out-





|xi ∈ X, yi ∈ Y , i = 1… n
}
 that comprised the 
n = 849 patients belonging to the two groups (persisting or 
non-persisting pain). Feature pre-selection (data analysis 
step 2; Fig. 2 right part) identified 39 parameters for which 
the analysis of probability of belonging to the “persisting 




 , was in principle possible. 
During feature selection (data analysis step 3; Fig. 2 right 
part), among these 39 candidates, ABC analysis picked 
21 parameters (features) six continuous and 15 discrete 
variables (Fig. 2) that provided a substantial contribu-
tion to the sensitivity and specificity of a classifier for a 
patient’s assignment to one of the groups (persisting pain 
or non-persisting pain). The process of feature selection 
via 1,000 resampling and ABC analyses is shown in Fig. 3 
for the 17 continuous variables, of which only six passed 
the analytical step due to their consistent placement in set 
“A” comprising the parameters most suitable as predictors.
A rule-based classifier [59] was obtained during analyti-
cal step 4 (Fig. 2 bottom right). It took the shape of a diag-
nostic tool shown in Table 2 consisting of a set of items 
presented as “yes” or “no” decisions. The diagnostic tool 
comprised three main categories of variables, i.e., demo-
graphic, psychological, and pain-related parameters (fea-
tures). For each item, the prediction of persistent pain, i.e., 
the assignment of a patient to the “persisting pain” group 
(output space), was likely at a specific threshold shown in 
the right column of Table 2. The number of positive deci-
sions by which a patient was classified into the “persist-
ing pain” group was established testing all possible feature 
combinations. This analysis resulted in a threshold of 9.5 
(Fig. 4), which indicates that when at least 10 of the 21 rules 
listed in Table 2 applied the patient was identified as likely 
to develop persistent pain. The detailed use of the diagnostic 
tool is described step-by-step in Textbox 1.
Textbox 1: Summary of the data acquisition 
and calculation steps required to apply 
the diagnostic tool, as presented in Table 2, 
to a single patient. See Table 1 for details 
about the items that need to be averaged
• Observation period for application of the predictive tool 
defined in Table 2 is 6 months after breast cancer surgery.
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• Query of demographic factors (age, BMI; items 1 and 2 
in Table 1).
• Query of complex psychological questionnaires (STAXI, 
preoperative), BDI, STAI state, and STAI trait at week 
24 postoperative (items 3–6 in Table 1).
• Query of pain-related ratings addressing how much the 
pain has affected the patient’s life or sleep during the 
last week, or querying the pain intensity, globally and 
also separately for various different body locations (items 
7–21 in Table 1).
– How much pain has affected the patient’s life is que-
ried using an 11-point NRS ranging from 0, not at 
all, to 10, very much (items 7–12 in Table 1). Items 
are queried at week 1, 4, and 24 at various body 
locations and averaged for week 4 across all body 
locations and for each of six body locations (breast, 
axilla, upper arm, joints, lower arm, hand/fingers) 
averaged across weeks 1, 4 and 24.
– How much pain has affected the patients sleep is 
queried using an 11-point NRS ranging from 0, not 
at all, to 10, very much (items 13–16 in Table 1). 
Items are queried at week 4 and 24, globally (items 
13 and 14 in Table 1), or asked specifically for the 
effect of pain at body locations breast or axilla. 
Items are queried at week 4 and 24 for the two 
body locations are averaged per body location 
(items 15 and 16 in Table 1).
Fig. 3  Performance of the continuous variables with a Bayesian deci-
sion boundary in 1,000 repeated cross-validations. The n = 17 contin-
uous variables were subjected to an ABC analysis (for ABC analysis, 
see [56]). The set A (best performers) was characterized by a sensitiv-
ity · specificity > 40% (threshold; magenta line). The resulting 6 vari-
ables in set A were included in the classifier construction. Names of 
variables above the threshold: Age, BMI, BDI0 = preoperative BDI, 
BDI1 = BDI at 1 month after surgery, BDI2 = BDI at 6 months after 
surgery, STAI0A, STAI1A, STAI2A = State anxiety (STAI) aquired 
preoperatively and  at 1 month and  6 months  after surgery, respec-
tively,  STAI0B, STAI1B, STAI2B = Trait anxiety (STAI) aquired 
preoperatively and  at 1 and  6 months  postoperatively, respectively, 
STAXI = Anger inhibition (STAXI)
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– Pain intensity in the operated-side arm and axilla 
(NRS from 0, no pain, to 10, worst imaginable 
pain), in the morning is queried at week 4 and 24 
and averaged across the time points (item 17 in 
Table 1)
– The worst pain intensity experienced during the 
past week (items 18–21 in Table 1) is queried for 
six body locations (breast, axilla, upper arm, joints, 
lower arm, hand/fingers) and in addition, for any part 
of the body (“somewhere”) using an 11-point NRS 
ranging from 0, not at all, to 10, very much. Items are 
queried at week 4 and 24 averaged per week across 
all body locations (items 18 and 19 in Table 1). Rat-
ings for pain in the operated breast or “somewhere” 
are averaged across weeks 4 and 24 (items 20 and 21 
in Table 1)
• Each of the 21 items (Table 1) obtained as described 
above is assessed with respect to the Bayesian threshold 
(Table 2, right column) and the sum of the “yes”/”no” 
answers to the question: “Above threshold?” are added.
• Persistent pain is likely when the above sum equals 10 or 
higher.
Classifier performance
At the end of analytical step 4, the performance of the 
obtained classifiers to correctly assign a patient to the per-
sisting pain groups was tested and compared with that of 
the previously proposed six-factor risk index for persisting 
pain [49] comprising the weighted items “age,” “chronic 
pain of any kind,” “number of previous operations,” “body 
mass index,” “preoperative pain in the area to be operated,” 
and “smoking,” This provided a performance of 70.6% sen-
sitivity and 45.4% specificity for correct assignment of a 
patient to the persisting pain group. The accuracy for cor-
rect group prediction was 47.4%, and the balanced accuracy, 
which takes unequal group sizes into account, was 57.9%. 
However, the negative predictive value, which quantifies the 
probability that persisting pain will not develop when the 
test is negative, was high with 94.5% correctly excluding a 
development toward persistent pain.
The novel, more complex, diagnostic tool provided, via 
1000 Monte-Carlo random resamplings [18] of 50% of the 
original data set, a cross-validated classifier performance 
of 79.3 ± 1.5% sensitivity and 51.4 ± 6% specificity for cor-
rect assignment of a patient to the persisting pain group. 
Table 2  Parameters (predictive factors) for persisting pain following breast cancer surgery
A patient is likely to develop persistent pain if at least 10 of the 21 items (rules) apply
BMI body mass index, BDI Beck’s Depression Inventory, STAI Spielberger’s State-Trait Anxiety Inventory, STAXI Spielberger’s State-Trait 
Anger Expression Inventory, m months
Number Category Parameters (predictive factors) Threshold
1 Demographic factors Age > 62
2 BMI > 31.5
3 Psychological factors Depressive symptoms (BDI) > 11
4 State anxiety (STAI) > 35
5 Trait anxiety (STAI) > 37
6 Anger inhibition (STAXI) > 12
7 Pain-related factors Have the pains in the extremities *affected your life? > 1.5
8 Have the pains in the axilla affected your life? > 0.5
9 Have the pains in the hand or fingers affected your life? > 0.5
10 Have the pains in the joints affected your life? > 0.5
11 Have the pains in the lower arm affected your life? > 0.5
12 Have the pains in the upper arm affected your life? > 0.5
13 How much has the pain disturbed your sleep? > 0.5
14 How much has the pain disturbed your sleep? > 0.5
15 How much has the pain in the axilla disturbed your sleep? > 0.5
16 How much has the pain in the breast disturbed your sleep? > 0.5
17 Pain intensity in the operated-side arm and axilla in the morning? > 2.5
18 Worst pain intensity during the past week at one month > 1.5
19 Worst pain intensity during the past week at 6 months > 0.5
20 Worst pain intensity during the past week in the operated breast? > 1.5
21 Worst pain intensity during the past week somewhere? > 1.5
All “Persistent pain” class if sum of positively answered items ≥ 10
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The overall classification accuracy obtained in the 1,000 
runs with resampled data was 86.2 ± 1.4%, and the bal-
anced accuracy was 65.4%. The negative predictive value 
was again high with 94.8% (binomial confidence interval: 
93.4–95.9%).
Finally, the classifier performances were assessed on the 
143 patients who did not completely meet the strict criteria 
of persistent pain but nevertheless displayed an unsatisfac-
tory course of pain development and were therefore used as 
an exploratory “test” data set. Thus, when only the first cri-
terion of the NRS-based classification into persisting and 
non-persisting pain groups was applied, i.e., patients with 
NRS ≤ 3 at month 36 after surgery (NRSmonth36 ≤ 3) were 
identified as belonging to the “non-persisting pain” group, 
while those with  (NRSmonth36 ≥ 4) had “persisting pain,” 
143 patients could be classified. Of these, 21 patients had 
at 3 years a pain score of ≥ 4 and were therefore considered 
as having an unfavorable clinical outcome. These patients 
were thus defined as “presumably having persisting pain” 
and therefore belonging to the “persisting pain” group. 
Taking the aforementioned unfavorable outcome as a sign 
of persisting pain, the 6-item classifier provided sensitivity 
and specificity of identifying potentially persisting pain of 
94.1 and 43.7%, respectively, and an accuracy or balanced 
accuracy of class assignment of 46.6 or 66.9%, respec-
tively. The more complex novel classifier provided 14 true 
positive, 3 false negative, 56 false positive, and 70 true 
negative diagnoses of persistent pain. This translates into 
sensitivity and specificity of identifying a patient at risk 
of 82.4 and 55.6%, respectively. The accuracy was 58.7%, 
the balanced accuracy was 69%, and a negative predictive 
value of 95.9% was obtained (binomial confidence interval: 
88.5–99.1%).
Fig. 4  Plot of the specificity versus the sensitivity of using all pos-
sible combinations and thresholds for the 21 candidate predictors of 
persistent pain after breast cancer surgery (classifier construction). 
The number of conditions for a positive classification into the “per-
sisting pain” groups ranges from n = 1–20 conditions. For all of these 
positive conditions, the sensitivity, specificity, and the area under the 
curve (AUC = sensitivity · specificity) was calculated. The red dots in 
the figure show AUC versus sensitivity. The black numbers close to 
the red dots indicate the number of conditions to be true according to 
the questions in Table 2. The maximum AUC, i.e., the best number of 
conditions for a classifier, was obtained with at least 10 positive items 
from Table 2, which was the result of the analysis shown in this figure 
and the reason why the final predictive tool required 10 or more posi-
tive items. The blue dots in the blue line indicate the corresponding 
specificity (ordinate) versus sensitivity (abscissa) values. The lines 
have been drawn to enhance visibility and are spline interpolations
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Discussion
The main result from the present machine-learned analysis 
was that a more complex diagnostic tool than previously 
proposed for a subgroup of 489 of the present patients [49] 
improved the correct assignment of a patient to either the 
persistent or non-persistent pain group, raising accuracy to 
86% and balanced accuracy to 65.4%, while maintaining the 
already high negative predictive value for persistent pain of 
95%.
The present criteria of persistent pain differed from the 
proposal of the International Association for the Study of 
Pain in two aspects, i.e., (i) the time window was longer, six 
months instead of two, due to the particular clinical setting 
of breast cancer surgery, and (ii) the presence of relevant pre-
operative pain jeopardizing the attribution of postoperative 
pain to the surgery. Eleven patients of the “persisting pain” 
group had an NRS value > 3 for preoperative pain. In nine 
of the 74 patients assigned to the “persisting pain” group 
(12%), pain at 36 months was less although still > 3/10 NRS. 
Thus, the definitive criteria for postsurgery pain were not 
met in these patients and the predictor correctly addressed 
persistent pain in a breast cancer setting without unequivo-
cally implying a surgical procedure as a causal factor. This 
should be considered when interpreting and applying the 
present diagnostic tool.
While in the original 6-item index “age,” “chronic pain 
of any kind,” “number of previous operations,” “body mass 
index,” “preoperative pain in the area to be operated,” and 
“smoking” were included, the novel selected features dif-
fered partly from this earlier selection. This probably owes 
to the longer observation period of the present analysis, and 
to the different techniques of feature selection. Nevertheless, 
some parameters agreed including a first major category of 
predictive features comprised demographic parameters. An 
increasing prevalence of chronic pain with age has been 
shown in several epidemiological studies [14]. The preva-
lence of neuropathic pain is also significantly higher in the 
elderly [53]. Interestingly, many previous, mainly cross-sec-
tional studies, have reported that younger age would increase 
the risk for persistent pain after breast cancer treatment [1]. 
Previous studies have usually included mild pain intensities, 
whereas we used at least moderate pain as a cut-off. Younger 
women may report more discomfort related to milder pain 
due to a more active life style. Similarly, high body weight 
and chronic pain have been suggested to represent signifi-
cant comorbidities, adversely impacting each other [40]. The 
association is not specific to a particular kind of pain but has 
been seen across several different aetiologies and clinical 
conditions [8, 20, 38, 40, 46, 60]. Possible physiological 
moderators include low-grade systemic inflammation and 
metabolic disorders [7, 29].
The second major category of predictive features empha-
sized the importance of psychological factors for the per-
sistence of pain. This is in line with evidence that psycho-
logical factors play an important role in pain persistence 
[4, 5, 11, 16, 27, 30, 31, 33, 34, 37]. Psychological factors 
and pain have bidirectional influences, i.e., psychological 
factors influence how the patient perceives and interprets 
pain and vice versa, constant pain may affect psychological 
factors and have an impact on mood either directly or via 
its negative effects on sleep, functionality, social, and other 
activities [57, 58]. Thus, psychological factors may be at the 
same time predictors, maintainers, changeable variables and 
consequences of persistent pain [13]. Therefore, psychologi-
cal factors have been proposed as early predictive markers 
for the development of persisting pain (e.g., [37]).
In the present study, women at risk of developing per-
sistent pain reported more symptoms of depression and 
state and trait anxiety. A higher tendency to inhibit anger, 
as assessed before surgery, was related to pain persistence. 
Anger inhibition has been suggested to be closely related to 
general negative affect and depressive symptoms [6], and 
thus to associate with chronic pain [21]. Similar associa-
tions of chronic pain with psychological factors have been 
reported in several clinical settings not restricted to can-
cer surgery [5, 16, 27, 31, 33, 34]. Feelings of anxiety and 
lowered mood preoperatively are natural reactions to a seri-
ous disease, especially immediately after diagnosis. Inter-
estingly, the level of psychological wellbeing at 6 months 
predicted persistent pain at 3 years, suggesting that better 
psychological coping after the acute phase might associate 
with lower risk of pain persistence. It might therefore be 
important to include routine assessment of psychological 
coping at this time point and initiate appropriate interven-
tions as needed.
Finally, the third major category of predictive features 
was related to pain. These features were present early on and 
continued to persist for up to 3 years. Indeed, this is a rec-
ognized observation and, due to this, early treatment of pain 
has become a clinical routine. Interestingly, the early percep-
tion that pain impacted the patient’s life did not closely cor-
relate with pain intensity. This was indicated by the lack of 
significant correlation between the ratings of the magnitude 
of the impact on the life and the associated NRS ratings of 
the pain intensity at the first month after surgery (Kendall’s 
τ = 0.136) [26, 55].
Conclusions
Using a data-driven approach in a cohort of 1,000 women 
operated on for breast cancer, a set of demographic, psycho-
logical, and pain-related parameters available not later than 
at 6 months after surgery was associated with the persistence 
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of pain in a 3-year follow-up. Applying machine-learning 
techniques, a classifier was developed that finally took the 
shape of a questionnaire with “yes/no” decisions about clini-
cal features. Its main clinical strength lies in the exclusion 
of the possibility of developing persistent pain in a woman 
being treated for breast cancer with an accuracy of 95% 
(negative predictive value). This provides a clinically reli-
able basis to release a patient early from multidisciplinary 
therapy approaches [9]. However, with not more than 80% 
sensitivity and roughly 70% specificity, the performance of 
the novel classifier in predicting chronic pain in a patient 
remained only moderate. This suggests that the demo-
graphic, psychological, and clinical parameters included in 
the present classifier are insufficient as predictors of persis-
tent pain. Future improvements should be searched for in 
“omics,” i.e., features based on proteomics, lipidomics, or 
genomics, to achieve the clinically desired early identifica-
tion of patients who will develop persistent pain following 
surgery for breast cancer.
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